Based on our DecisionBase 2010 report entitled Psoriasis: Dermatologists Identify Remaining Opportunities as the Number of Highly Efficacious Biologics Continues to Grow, Decision Resources is offering an exclusive webinar entitled What Key Drug Attributes Will Emerging Therapies Need to Erode the Dominance of TNF-alpha Inhibitors in Moderate to Severe Psoriasis? Because this webinar features major report findings, it is ONLY available to purchasers of this report.
This webinar was held on March 31, 2010. Contact us to learn how you can purchase this report and access a recorded playback of this event.
Click here to view the invite.